Novel Aptamers for Diagnosis and Therapy of Human Glioblastoma

We offer novel high affinity aptamer sequences that target the zinc finger motif of the glioblastoma oncogene protein. The specificity of aptamers to different zinc finger transcription factors, which are to a large extend involved in human diseases, has the potential for valuable new agents for diagnostic and therapeutic application.

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Ursula Haufe

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Duke-NUS and NHCS scientists first in the world to regenerate diseased kidney

Blocking an immune-regulating protein reverses the damage caused by acute and chronic kidney disease, a preclinical study suggests. In a world first, scientists at Duke-NUS Medical School, the National Heart…

Unconventional superconductivity found in kagome metal

Physicists using advanced muon spin spectroscopy at Paul Scherrer Institute PSI make the missing link between their recent breakthrough in a kagome metal and unconventional superconductivity. The team uncovered an…

Discovery of new ice may change understanding of water

Researchers at UCL (University College London) have discovered a new type of ice that more closely resembles liquid water than any other known ices and that may rewrite our understanding…

Partners & Sponsors